United States In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

United States In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalDatas new report, United States In Vitro Diagnostics (IVD) Market Outlook to 2024, provides key market data on the United States In Vitro Diagnostics (IVD) market. The report provides value, in millions of US dollars and volume (in units) within market categories - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for In Vitro Diagnostics (IVD) market categories - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2010 to 2017 and forecast to 2024.
- 2017 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the United States In Vitro Diagnostics (IVD) market.
- Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Sysmex Corp, Siemens Healthcare GmbH, Beckman Coulter Inc, Thermo Fisher Scientific Inc and Others

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.

2
1.List of Tables 5
1.2 List of Figures 19
2 Introduction 24
2.What Is This Report About? 24
2.2 In Vitro Diagnostics (IVD) Market Segmentation 24
2.3 Definitions of Markets Covered in the Report 28
3 In Vitro Diagnostics Market, United States 51
3.In Vitro Diagnostics Market, United States, Revenue ($m), 2010-2024 51
3.2 In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2017 53
3.3 In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2017 54
3.4 In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), 2009-2023 56
3.5 In Vitro Diagnostics Market, United States, Revenue ($m), 2010-2017 58
3.6 In Vitro Diagnostics Market, United States, Revenue ($m), 2017-2024 60
3.7 In Vitro Diagnostics Market, United States, Volume (Units), 2010-2024 62
3.8 In Vitro Diagnostics Market, United States, Volume (Units), 2010-2017 64
3.9 In Vitro Diagnostics Market, United States, Volume (Units), 2017-2024 66
3.10 In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), 2017 68
4 Clinical Chemistry Market, United States 70
4.Clinical Chemistry Market, United States, Revenue Mix ($m), 2017 70
4.2 Clinical Chemistry Market, United States, Segment Contribution (%), 2017 71
4.3 Clinical Chemistry Market, United States, Revenue ($m), 2010-2017 73
4.4 Clinical Chemistry Market, United States, Revenue ($m), 2017-2024 75
4.5 Clinical Chemistry Market, United States, Volume (Units), 2010-2017 109
4.6 Clinical Chemistry Market, United States, Volume (Units), 2017-2024 111
4.7 Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 137
4.8 Clinical Chemistry Market, United States, Company Share by Revenue ($m), 2017 138
5 Genetic Testing Market, United States 140
5.Genetic Testing Market, United States, Revenue Mix ($m), 2017 140
5.2 Genetic Testing Market, United States, Segment Contribution (%), 2017 141
5.3 Genetic Testing Market, United States, Revenue ($m), 2010-2017 142
5.4 Genetic Testing Market, United States, Revenue ($m), 2017-2024 144
5.5 Genetic Testing Market, United States, Distribution Share by Revenue ($m), 2017 146
5.6 Genetic Testing Market, United States, Company Share by Revenue ($m), 2017 147
6 Hematology Market, United States 149
6.Hematology Market, United States, Revenue Mix ($m), 2017 149
6.2 Hematology Market, United States, Segment Contribution (%), 2017 150
6.3 Hematology Market, United States, Revenue ($m), 2010-2017 152
6.4 Hematology Market, United States, Revenue ($m), 2017-2024 154
6.5 Hematology Market, United States, Volume (Units), 2010-2017 180
6.6 Hematology Market, United States, Volume (Units), 2017-2024 182
6.7 Hematology Market, United States, Distribution Share by Revenue ($m), 2017 200
6.8 Hematology Market, United States, Company Share by Revenue ($m), 2017 201
7 Histology And Cytology Market, United States 203
7.Histology And Cytology Market, United States, Revenue Mix ($m), 2017 203
7.2 Histology And Cytology Market, United States, Segment Contribution (%), 2017 204
7.3 Histology And Cytology Market, United States, Revenue ($m), 2010-2017 206
7.4 Histology And Cytology Market, United States, Revenue ($m), 2017-2024 208
7.5 Histology And Cytology Market, United States, Distribution Share by Revenue ($m), 2017 210
7.6 Histology And Cytology Market, United States, Company Share by Revenue ($m), 2017 211
8 Immuno Chemistry Market, United States 213
8.Immuno Chemistry Market, United States, Revenue Mix ($m), 2017 213
8.2 Immuno Chemistry Market, United States, Segment Contribution (%), 2017 214
8.3 Immuno Chemistry Market, United States, Revenue ($m), 2010-2017 216
8.4 Immuno Chemistry Market, United States, Revenue ($m), 2017-2024 218
8.5 Immuno Chemistry Market, United States, Volume (Units), 2010-2017 252
8.6 Immuno Chemistry Market, United States, Volume (Units), 2017-2024 254
8.7 Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 288
8.8 Immuno Chemistry Market, United States, Company Share by Revenue ($m), 2017 289
9 Infectious Diagnostics Market, United States 291
9.Infectious Diagnostics Market, United States, Revenue Mix ($m), 2017 291
9.2 Infectious Diagnostics Market, United States, Segment Contribution (%), 2017 292
9.3 Infectious Diagnostics Market, United States, Revenue ($m), 2010-2017 294
9.4 Infectious Diagnostics Market, United States, Revenue ($m), 2017-2024 297
9.5 Infectious Diagnostics Market, United States, Volume (Units), 2010-2017 344
9.6 Infectious Diagnostics Market, United States, Volume (Units), 2017-2024 347
9.7 Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2017 396
9.8 Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2017 397
10 Microbiology Culture Market, United States 399
10.Microbiology Culture Market, United States, Revenue Mix ($m), 2017 399
10.2 Microbiology Culture Market, United States, Segment Contribution (%), 2017 400
10.3 Microbiology Culture Market, United States, Revenue ($m), 2010-2017 402
10.4 Microbiology Culture Market, United States, Revenue ($m), 2017-2024 404
10.5 Microbiology Culture Market, United States, Distribution Share by Revenue ($m), 2017 414
10.6 Microbiology Culture Market, United States, Company Share by Revenue ($m), 2017 415
1Overview of Key Companies in United States, In Vitro Diagnostics Market 417
11.F. Hoffmann-La Roche Ltd 417
11.2 Beckman Coulter Inc 417
11.3 Abbott Laboratories 417
11.4 Becton Dickinson and Co 417
11.5 Siemens Healthcare GmbH 418
11.6 Thermo Fisher Scientific Inc 418
11.7 Hologic Inc 418
11.8 Sysmex Corp 419
11.9 bioMerieux SA 419
11.10 Ortho-Clinical Diagnostics Inc 419
11.1Bio-Rad Laboratories Inc 419
11.12 Qiagen NV 420
11.13 Alere Inc 420
11.14 DiaSorin S.p.A 420
12 In Vitro Diagnostics Market Pipeline Products 421
13 Financial Deals Landscape 425
13.Acquisition 425
13.2 Asset Transactions 461
13.3 Debt Offerings 477
13.4 Equity Offerings 587
13.5 Merger 744
13.6 Partnerships 747
13.7 Private Equity 925
13.8 Venture Financing 936
14 Recent Developments 1084
14.Corporate Communications 1084
14.2 Financial Announcements 1356
14.3 Government and Public Interest 2168
14.4 Legal And Regulatory 2192
14.5 Other Significant Developments 2229
14.6 Product News 2367
14.7 Research And Development 2618
14.8 Strategy And Business Planning 2619
15 Appendix 2656
15.Research Methodology 2657
15.2 GlobalData Consulting 2661
15.3 Contact Us 2662
15.4 Disclaimer 2662

List Of Tables

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2010-2024 119
Table 2: In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2017 122
Table 3: In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), 2009-2023 124
Table 4: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 126
Table 5: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 128
Table 6: In Vitro Diagnostics Market, United States, Volume (Units), 2010-2024 130
Table 7: In Vitro Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 132
Table 8: In Vitro Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 134
Table 9: In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2017 136
Table 10: Clinical Chemistry Market, United States, Segment Contribution (%), 2017 139
Table 11: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 141
Table 12: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 143
Table 13: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 145
Table 14: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 147
Table 15: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 149
Table 16: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 151
Table 17: Substrates Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 153
Table 18: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 155
Table 19: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 157
Table 20: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 159
Table 21: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 161
Table 22: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 163
Table 23: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 165
Table 24: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 167
Table 25: Substrates Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 169
Table 26: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 171
Table 27: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 173
Table 28: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 175
Table 29: Clinical Chemistry Market, United States, Volume (Units), Historic, 2010-2017 177
Table 30: Clinical Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 179
Table 31: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 181
Table 32: Clinical Chemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 183
Table 33: Enzyme Chemistry Reagents Market, United States, Volume (Units), Historic, 2010-2017 185
Table 34: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 187
Table 35: Substrates Market, United States, Volume (Units), Historic, 2010-2017 189
Table 36: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 191
Table 37: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 193
Table 38: Clinical Chemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 195
Table 39: Enzyme Chemistry Reagents Market, United States, Volume (Units), Forecast, 2017-2024 197
Table 40: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 199
Table 41: Substrates Market, United States, Volume (Units), Forecast, 2017-2024 201
Table 42: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 203
Table 43: Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016-2017 204
Table 44: Clinical Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017 206
Table 45: Genetic Testing Market, United States, Segment Contribution (%), 2017 208
Table 46: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 210
Table 47: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 212
Table 48: Genetic Testing Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 213
Table 49: Genetic Testing Market, United States, Company Share by Revenue ($m), USD Constant, 2017 215
Table 50: Hematology Market, United States, Segment Contribution (%), 2017 218
Table 51: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 220
Table 52: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 222
Table 53: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 224
Table 54: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 226
Table 55: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 228
Table 56: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 230
Table 57: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 232
Table 58: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 234
Table 59: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 236
Table 60: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 238
Table 61: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 240
Table 62: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 242
Table 63: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 244
Table 64: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 246
Table 65: Hematology Market, United States, Volume (Units), Historic, 2010-2017 248
Table 66: Hematology Market, United States, Volume (Units), Forecast, 2017-2024 250
Table 67: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017 252
Table 68: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 254
Table 69: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017 256
Table 70: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017 258
Table 71: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 260
Table 72: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 262
Table 73: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024 264
Table 74: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024 266
Table 75: Hematology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 267
Table 76: Hematology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 269
Table 77: Histology And Cytology Market, United States, Segment Contribution (%), 2017 272
Table 78: Histology And Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 274
Table 79: Histology And Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 276
Table 80: Histology And Cytology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 277
Table 81: Histology And Cytology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 279
Table 82: Immuno Chemistry Market, United States, Segment Contribution (%), 2017 282
Table 83: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 284
Table 84: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 286
Table 85: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 288
Table 86: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 290
Table 87: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 292
Table 88: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 294
Table 89: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 296
Table 90: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 298
Table 91: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 300
Table 92: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 302
Table 93: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 304
Table 94: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 306
Table 95: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 308
Table 96: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 310
Table 97: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 312
Table 98: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 314
Table 99: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 316
Table 100: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 318
Table 101: Immuno Chemistry Market, United States, Volume (Units), Historic, 2010-2017 320
Table 102: Immuno Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 322
Table 103: Complement Deficiency Tests Market, United States, Volume (Units), Historic, 2010-2017 324
Table 104: Diabetes Assays Market, United States, Volume (Units), Historic, 2010-2017 326
Table 105: Disease Specific Immunochemistry Market, United States, Volume (Units), Historic, 2010-2017 328
Table 106: Endocrinology Tests Market, United States, Volume (Units), Historic, 2010-2017 330
Table 107: IgE Allergy Blood Tests Market, United States, Volume (Units), Historic, 2010-2017 332
Table 108: Immunochemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 334
Table 109: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 336
Table 110: Vitamins Tests Market, United States, Volume (Units), Historic, 2010-2017 338
Table 111: Complement Deficiency Tests Market, United States, Volume (Units), Forecast, 2017-2024 340
Table 112: Diabetes Assays Market, United States, Volume (Units), Forecast, 2017-2024 342
Table 113: Disease Specific Immunochemistry Market, United States, Volume (Units), Forecast, 2017-2024 344
Table 114: Endocrinology Tests Market, United States, Volume (Units), Forecast, 2017-2024 346
Table 115: IgE Allergy Blood Tests Market, United States, Volume (Units), Forecast, 2017-2024 348
Table 116: Immunochemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 350
Table 117: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 352
Table 118: Vitamins Tests Market, United States, Volume (Units), Forecast, 2017-2024 354
Table 119: Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 355
Table 120: Immuno Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017 357
Table 121: Infectious Diagnostics Market, United States, Segment Contribution (%), 2017 360
Table 122: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 362
Table 123: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 365
Table 124: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 368
Table 125: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 370
Table 126: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 372
Table 127: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 374
Table 128: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 376
Table 129: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 378
Table 130: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 380
Table 131: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 382
Table 132: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 384
Table 133: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 386

Clinical Laboratory Services Market in United States - 2023 Edition

Clinical laboratories are healthcare facilities providing a wide range of laboratory procedures which aid the physicians in carrying out the diagnosis, treatment, and management of patients. Laboratory services are provided

USD 2650 View Report

United Kingdom Spinal Surgery Market Outlook to 2025 - Minimal Invasive Spinal Devices, Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems and Vertebral Compression Fracture Repair Devices

United Kingdom Spinal Surgery Market Outlook to 2025 - Minimal Invasive Spinal Devices, Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems and Vertebral Compression Fracture Repair Devices United Kingdom Spinal

USD 4995 View Report

United States Cellular Full Year Operating Financial

United States Cellular 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Telecommunications IndustryThis report is part of the

USD 750 View Report

United States Steel Full Year Operating Financial

United States Steel 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Mining and Metals Industry This report is part

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available